SNYDER, GRETCHEN,DAVIS, ROBERT,WENNOGLE, LAWRENCE P.
申请号：
CA3094204
公开号：
CA3094204A1
申请日:
2019.03.15
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The disclosure provides methods for the acute treatment of depression and/or anxiety, for the enhancement of mTOR (e.g., mTORC1) signaling, and for the reduction of neuroinflammation, comprising administering to a patient in need thereof, a therapeutically effective amount of a 5-HT2A or 5-HT2A/D2 receptor ligand, e.g. lumateperone.
